Supporting for interventions that aim to modify or edit APOE comes from the recent report that homozygosis for the APOE3 Christchurch variant (R136S) markedly delayed cognitive decline in a single presenilin 1 (PSEN1) mutation carrier [146]. The gene discussed is PSEN1; the disease is Mental deterioration.